Xishan Hao

6.7k total citations
150 papers, 5.1k citations indexed

About

Xishan Hao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xishan Hao has authored 150 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 60 papers in Molecular Biology and 39 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xishan Hao's work include Gastric Cancer Management and Outcomes (18 papers), Immune Cell Function and Interaction (14 papers) and RNA modifications and cancer (13 papers). Xishan Hao is often cited by papers focused on Gastric Cancer Management and Outcomes (18 papers), Immune Cell Function and Interaction (14 papers) and RNA modifications and cancer (13 papers). Xishan Hao collaborates with scholars based in China, United States and Canada. Xishan Hao's co-authors include Jinpu Yu, Kexin Chen, Baocun Sun, Xiubao Ren, Shiwu Zhang, Xiulan Zhao, Ruifang Niu, Jingyu Deng, Rupeng Zhang and Fengju Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xishan Hao

143 papers receiving 5.0k citations

Peers

Countries citing papers authored by Xishan Hao

Since Specialization

Citations

This map shows the geographic impact of Xishan Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xishan Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xishan Hao more than expected).

Fields of papers citing papers by Xishan Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xishan Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xishan Hao. The network helps show where Xishan Hao may publish in the future.

Co-authorship network of co-authors of Xishan Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xishan Hao. A scholar is included among the top collaborators of Xishan Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xishan Hao. Xishan Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses 2025 ·Journal of Hepatology ·Hongfeng Yuan, Lina Zhao, Guang Yang, (unknown), (unknown), Shuqin Zhang, Yufei Wang, (unknown), (unknown), Yunxia Liu, Yu Geng, Huihui Zhang, Xiuzhu Gao, Xiaomei Wang, (unknown), Ming Yin, (unknown), Junqi Niu, Xishan Hao, (unknown)	0
2	Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer 2024 ·Frontiers in Immunology ·Huijing Feng, Siyuan Zhang, (unknown), (unknown), Gang Du, Lin Wang, Xuena Yang, Xi‐Ying Zhang, (unknown), Wei Feng, Xishan Hao, Xiubao Ren, Hua Zhao	3
3	LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY 2019 ·Cancer Research ·Rui Zhang, Fan Zhang, Zeguo Sun, Pengpeng Liu, Xiao Zhang, Yingnan Ye, (unknown), Martin J. Walsh, Xiubao Ren, Xishan Hao, Weijia Zhang, Jinpu Yu	33
4	CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia 2015 ·Clinical Cancer Research ·Fengting Liu, Li Jia, Ping Wang, Timothy Farren, Hong Li, Xishan Hao, Samir Agrawal	15
5	Integrated MicroRNA Network Analyses Identify a Poor-Prognosis Subtype of Gastric Cancer Characterized by the miR-200 Family 2013 ·Clinical Cancer Research ·Fengju Song, Da Yang, Ben Liu, Yan Guo, Hong Zheng, Lian Li, Tao Wang, Jinpu Yu, Yanrui Zhao, Ruifang Niu, Han Liang, Hans Winkler, Wei Zhang, Xishan Hao, Kexin Chen	94
6	Prognostic analysis of patients with advanced gastric cancer undergoing intraoperative chemohyperthermic peritoneal perfusion 2012 ·Clinical Oncology and Cancer Research ·(unknown), Han Liang, Baogui Wang, (unknown), Xishan Hao	3
7	Synergistic Effect of CH-296 and Interferon Gamma on Cytokine-Induced Killer Cells Expansion for Patients with Advanced-Stage Malignant Solid Tumors 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·Jinpu Yu, Xiubao Ren, Hui Li, Shui Cao, Ying Han, Tatsuji Enoki, Ikunoshin Kato, Chunyu Cao, Xishan Hao	14
8	Definition of a Functional Single Nucleotide Polymorphism in the Cell Migration Inhibitory Gene MIIP That Affects the Risk of Breast Cancer 2010 ·Cancer Research ·Fangfang Song, Ping Ji, Hong Zheng, Fengju Song, Yingmei Wang, Xishan Hao, Qingyi Wei, Wei Zhang, Kexin Chen	16
9	mTOR Complex Component Rictor Interacts with PKCζ and Regulates Cancer Cell Metastasis 2010 ·Cancer Research ·Fei Zhang, Xiaofang Zhang, Menghui Li, Peng Chen, Bin Zhang, Hua Guo, Wenfeng Cao, (unknown), Xuchen Cao, Xishan Hao, Ning Zhang	105
10	A phase I clinical trial of vincristine sulfate liposome:tolerance and safety evaluation of successive administration 2010 ·Chinese Journal of New Drugs and Clinical Remedies ·Xishan Hao	1
11	Pharmacokinetics of 9-nitrocamptothecin capsule in patients with advanced solid tumors 2009 ·Chinese Journal of New Drugs and Clinical Remedies ·Xishan Hao	1
12	Lymph Node Metastases from Carcinoma of the Thoracic Esophagus and Gastric Cardia: A Random Sampling Report 2008 ·Clinical Oncology and Cancer Research ·Xishan Hao	1
13	Immunologic response to primary cryoablation of high-risk prostate cancer 2008 ·Cryobiology ·Tongguo Si, Zhixing Guo, Xishan Hao	26
14	Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer 2008 ·BMC Cancer ·Bin Zhang, Xuchen Cao, Yanxue Liu, Wenfeng Cao, Fei Zhang, Shiwu Zhang, Hongtao Li, Liansheng Ning, Li Fu, Yun Niu, Ruifang Niu, Baocun Sun, Xishan Hao	131
15	Synergistic effects of proteasome inhibitor on TRAIL-induced apoptosis in malignant lymphoma cells 2007 ·Clinical Oncology and Cancer Research ·Jihui Hao, Ming Yu, Jia Li, Fengting Liu, Qiang Li, Xishan Hao	1
16	Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients 2007 ·IUBMB Life ·Man Yu, Yunli Zhou, Yurong Shi, Liansheng Ning, Yi Yang, Xiyin Wei, Ning Zhang, Xishan Hao, Ruifang Niu	210
17	Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived Immunosuppressive Molecule IDO through RNA Interference 2006 ·The Journal of Immunology ·Xiufen Zheng, James Koropatnick, Mu Li, Xusheng Zhang, (unknown), Xiubao Ren, Xishan Hao, Hongtao Sun, Costin Vladau, Jacob Franek, Biao Feng, Bradley L. Urquhart, Robert Zhong, David J. Freeman, Bertha García, Wei-Ping Min	83
18	Th1 Polarization and Apoptosis-Inducing Activity of CD4 ⁺ T -Cells in Cytokine-Induced Killers Might Favor the Antitumor Cytotoxicity of Cytokine-Induced Killers In Vivo 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·Jinpu Yu, Xiubao Ren, Shui Cao, Weihong Zhang, Xishan Hao	12
19	Pilot Study of Molecular Mechanism on Vasculogenic Mimicry in Bi-directional Differentiated Malignant Tumors 2005 ·The Chinese-German Journal of Clinical Oncology ·Baocun Sun, Shiwu Zhang, Xiulan Zhao, Danfang Zhang, Xishan Hao	4
20	The application of FJI and its comparison with different alimentary reconstructions after total gastrectomy for cancer 2002 ·The Chinese-German Journal of Clinical Oncology ·Xishan Hao, Qiang Li, Jian Yin	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact